High Purity 99% Peptides Cagrilintide Cartridge Weight Loss CAS 1415456-99-3 Increase metabolism
TDS 66 Inquiries
1415456-99-3
Pharmaceutical Grade
99%
vials Cartridge APIs
Yes
2028-06-07
Retatrutide,Tirzepatide,Semaglutide,TB500,HGH Fragment 176-191,GHK-Cu (Copper Peptide)
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Certificates-
TDS
Basic Info-
Product Name:
Cagrilintide
Other Name:Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide
CAS No.:1415456-99-3
Molecular Formula:C194H312N54O59S2
Molecular Weight:0
EC Number:206-141-6
Color/Form:White to off-white
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,Semaglutide,TB500,HGH Fragment 176-191,GHK-Cu (Copper Peptide)
-
Location:
1-1, Building 19, No. 78, Shengli Road, Xinzhou District, Shangrao City, Jiangxi Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
7 days
-
Total Employees:
Above 1000
-
Year of Establishment:
2023
Company Certificates-
GMP
-
FDA
-
Semaglutide COA
-
Tirzepatide COA
-
Retatrutide COA
-
-
Inquiry History66 Inquiries
Country Product Purchase Quantity Date Posted
United States
Cagrilintide
20 MG Sep 30, 2026
Australia
Cagrilintide
20 MG Aug 17, 2026
United Kingdom
Cagrilintide
10 MG Jul 31, 2026
France
Cagrilintide
10 MG May 22, 2026
Australia
Cagrilintide
4 MT Mar 9, 2026
United States
Cagrilintide
15 MG Feb 25, 2026
United States
Cagrilintide
10 PCS Dec 27, 2025
United States
Cagrilintide
2 MT Dec 21, 2025
United States
Cagrilintide
100 MG Oct 28, 2025
United States
cagrilintide
2 MT Aug 8, 2025
Philippines
Retatrutide
5 MG Aug 5, 2025
China
Cagrilintide
100 G May 6, 2025
United States
cagrilintide
5 MG Feb 18, 2025
United States
Cagrilintide
3 MT Feb 7, 2025
United States
Cagrilintide
100 Nov 12, 2024
United States
Cagrillintide Lyophilized powder
100 MG Jul 4, 2024
United States
Cagrillintide Lyophilized powder
1000 MG Apr 20, 2024
United States
Cagrilintide
10 MG Sep 23, 2026
United States
Cagrilintide
25 MG Aug 31, 2026
United States
Cagrlintide
1 MT Jul 31, 2026 Post an enquiry for this product
More from this Seller
-
-
-
FDA registered Semaglutide APIs CAS NO: 910463-68-2 purity 99%
Pharmaceutical Grade / 99.7%
$100-130/G EXW
-
-
-
-
FDA registered Retatrutide APIs CAS NO: 2381089-83-2 purity 99%
Pharmaceutical Grade / 99%
$200-260/G EXW
-
-
-
-
CAS 53-84-9 NAD+Cartridge Nicotinamide Adenine Dinucleotide | US Warehouse | Peptides | 99% Purity | 500mg 1000mg Vial | Lyophilized Powder
Pharmaceutical Grade / 99%
$250-260/KG EXW
-
-
-
-
99% high purity TB500 Cartridge CAS-885340-08-9 Manufacturers straight transport fast quality
Pharmaceutical Grade / 99%
$250-280/G EXW
-
-
-
-
FDA registered Tirzepatide APIs CAS NO: 2023788-19-2 purity 99%
Pharmaceutical Grade / 99.3%
$150-190/G EXW
-




